ZNF512B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.324400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.763400E-01
Normal-vs-Stage2
2.667400E-01
Normal-vs-Stage3
4.528100E-02
Normal-vs-Stage4
6.138600E-01
Stage1-vs-Stage2
2.992800E-01
Stage1-vs-Stage3
1.904970E-01
Stage1-vs-Stage4
5.770800E-01
Stage2-vs-Stage3
3.384600E-01
Stage2-vs-Stage4
6.535400E-01
Stage3-vs-Stage4
3.511600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.859000E-01
Normal-vs-AfricanAmerican
3.434400E-02
Normal-vs-Asian
1.279970E-01
Caucasian-vs-AfricanAmerican
1.711840E-01
Caucasian-vs-Asian
2.258400E-01
AfricanAmerican-vs-Asian
7.112800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.942000E-01
Normal-vs-Female
5.045000E-01
Male-vs-Female
3.536400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.707400E-01
Normal-vs-Age(41-60Yrs)
6.163000E-01
Normal-vs-Age(61-80Yrs)
3.392600E-01
Normal-vs-Age(81-100Yrs)
1.997840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.177760E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.811400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.560800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.324370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.584000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.126000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.447600E-01
Normal-vs-Daily Drinker
5.719200E-01
Normal-vs-Weekly Drinker
7.282000E-01
Normal-vs-Occasional Drinker
7.032200E-01
Normal-vs-Social Drinker
6.100400E-01
Non Drinker-vs-Daily Drinker
3.750000E-01
Non Drinker-vs-Weekly Drinker
1.290760E-01
Non Drinker-vs-Occasional Drinker
1.693760E-01
Non Drinker-vs-Social Drinker
2.644800E-01
Daily Drinker-vs-Weekly Drinker
5.810000E-01
Daily Drinker-vs-Occasional Drinker
6.747600E-01
Daily Drinker-vs-Social Drinker
8.246400E-01
Weekly Drinker-vs-Occasional Drinker
8.812200E-01
Weekly Drinker-vs-Social Drinker
7.347400E-01
Occasional Drinker-vs-Social Drinker
8.523000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.877200E-01
Normal-vs-Grade 2
9.713000E-01
Normal-vs-Grade 3
9.456000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.871850E-01
Grade 1-vs-Grade 3
5.643000E-01
Grade 1-vs-Grade 4
7.877200E-01
Grade 2-vs-Grade 3
1.253810E-01
Grade 2-vs-Grade 4
9.713000E-01
Grade 3-vs-Grade 4
9.456000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.294180E-01
Normal-vs-NonDiabetic
5.897000E-01
Diabetic-vs-NonDiabetic
3.616000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.356800E-01
Normal-vs-NoPancreatitis
4.426600E-01
Pancreatitis-vs-NoPancreatitis
8.484800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.374400E-01
Normal-vs-N1
2.882400E-01
N0-vs-N1
6.237000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.176400E-01
Normal-vs-TP53-NonMutant
6.754400E-01
TP53-Mutant-vs-TP53-NonMutant
6.265800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
